General Automation Lab Technologies: Funding & Investors (Sep 2026)
GALT is a developer of a microbiological technology used to help cultivate and study bacteria and other microbes. Its platform develops novel technologies that vastly increase the ability to study microbes, the single most diverse and impact group of organisms on the planet that enable scientists to uncover deeper insights into microbiome-based applications in agriculture, human health, environment, and industry. The company's mission is to transform microbiome science through high-throughput microbial isolation and cultivation array system. General Automation Lab Technologies was established in 2014 and is headquartered in San Carlos, California.
General Automation Lab Technologies has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Dec 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
General Automation Lab Technologies Company Profile and Key Stats
Latest funding round on record: Dec 2020.
General Automation Lab Technologies Funding Rounds
General Automation Lab Technologies Founders and Leadership Team
Contact details for the General Automation Lab Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →General Automation Lab Technologies Funding Compared to Other Biotechnology Startups
General Automation Lab Technologies' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like General Automation Lab Technologies in Biotechnology and San Carlos
Companies Similar to General Automation Lab Technologies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
General Automation Lab Technologies Funding FAQs
What does General Automation Lab Technologies do?
GALT is a developer of a microbiological technology used to help cultivate and study bacteria and other microbes. Its platform develops novel technologies that vastly increase the ability to study microbes, the single most diverse and impact group of organisms on the planet that enable scientists to uncover deeper insights into microbiome-based applications in agriculture, human health, environment, and industry. The company's mission is to transform microbiome science through high-throughput microbial isolation and cultivation array system. General Automation Lab Technologies was established in 2014 and is headquartered in San Carlos, California.
How much funding has General Automation Lab Technologies raised?
General Automation Lab Technologies has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Dec 2020.
When did General Automation Lab Technologies last raise funding?
General Automation Lab Technologies' most recent funding round on record is an undisclosed round of $15.0M, announced in Dec 2020.
Who is the CEO of General Automation Lab Technologies?
Peter Christey is listed as CEO at General Automation Lab Technologies.
Where is General Automation Lab Technologies headquartered?
General Automation Lab Technologies is based in San Carlos, California, United States.
How many employees does General Automation Lab Technologies have?
General Automation Lab Technologies is in the 11-50 employee band.
How does General Automation Lab Technologies' funding compare to other Biotechnology startups?
General Automation Lab Technologies' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's General Automation Lab Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for General Automation Lab Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.